Coffee is one of the most widely consumed beverages worldwide. It is usually identified as a
stimulant because of a high content of caffeine. However, caffeine is not the only coffee …

Caffeine is the most widely used psychostimulant in Western countries, with antioxidant, anti‐
inflammatory and anti‐apoptotic properties. In Alzheimer's disease (AD), caffeine is …

Caffeine is the most frequently used substance with a central nervous system stimulant
effect, but its consumption is most often due to the intake of foods and drinks that contain it …

This paper reviews the results of studies conducted on the role of caffeine in the
management of different neurological disorders, such as Parkinson's disease (PD) and …

Evidence demonstrates that chronic caffeine exposure, primarily through consumption of
coffee or tea, leads to increased alertness and anxiety. Preclinical and clinical studies …

Objective To perform a simultaneous evaluation of potential risk/protective factors of
Parkinson disease (PD) to identify independent risk/protective factors, to assess interaction …

Parkinson's disease (PD) is a neurodegenerative disorder whose pathogenesis depends on
a combination of genetic and environmental factors. The aim of the present review was to …

As the population ages, neurodegenerative diseases such as Parkinson's disease (PD) and
Alzheimer's disease (AD) impose a heavy burden on society and families. The …

Accumulative evidence indicated that the pathologically accumulated metal ions (iron
species and Mn3+) and abnormally up-regulated monoamine oxidase B (MAOB) activity …

The adenosine A2A receptor subtype is recognized as a non-dopaminergic
pharmacological target for the treatment of neurodegenerative disorders, notably …